FDA panel revisits Avandia, likely too late for diabetes drug

[riky]

FDA panel revisits Avandia, likely too late for diabetes drug

<p><a href="http://news.yahoo.com/fda-panel-revisits-avandia-likely-too-diabetes-drug-110256851.html"><img src="http://l2.yimg.com/bt/api/res/1.2/ey8N0l_g7jiBMYloNXVriA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-05T110256Z_1_CBRE9540UOZ00_RTROPTP_2_GLAXO-RESULTS.JPG" width="130" height="86" alt="A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company results" align="left" title="A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company results" border="0" /></a>By David Morgan WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel of outside experts reopened one of the biggest drug controversies in recent years on Wednesday at a meeting where they will decide whether to recommend lifting marketing restrictions on GlaxoSmithKline Plc's Avandia diabetes drug. The two-day FDA advisory committee meeting is not expected to bring about a major boost in sales for the onetime multibillion dollar product. But its findings may help revive the credibility of the British drugmaker's original research and shed light on the current U.S. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login